Form 8-K - Current report:
SEC Accession No. 0000950170-25-081601
Filing Date
2025-06-04
Accepted
2025-06-04 16:04:09
Documents
29
Period of Report
2025-06-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cgem-20250604.htm   iXBRL 8-K 52926
2 EX-99.1 cgem-ex99_1.htm EX-99.1 24825
3 EX-99.2 cgem-ex99_2.htm EX-99.2 27790
4 GRAPHIC cgem-ex99_2s1.jpg GRAPHIC 373757
5 GRAPHIC cgem-ex99_2s2.jpg GRAPHIC 809525
6 GRAPHIC cgem-ex99_2s3.jpg GRAPHIC 268867
7 GRAPHIC cgem-ex99_2s4.jpg GRAPHIC 581592
8 GRAPHIC cgem-ex99_2s5.jpg GRAPHIC 560525
9 GRAPHIC cgem-ex99_2s6.jpg GRAPHIC 445018
10 GRAPHIC cgem-ex99_2s7.jpg GRAPHIC 504125
11 GRAPHIC cgem-ex99_2s8.jpg GRAPHIC 358355
12 GRAPHIC cgem-ex99_2s9.jpg GRAPHIC 363585
13 GRAPHIC cgem-ex99_2s10.jpg GRAPHIC 413946
14 GRAPHIC cgem-ex99_2s11.jpg GRAPHIC 483960
15 GRAPHIC cgem-ex99_2s12.jpg GRAPHIC 358407
16 GRAPHIC cgem-ex99_2s13.jpg GRAPHIC 422962
17 GRAPHIC cgem-ex99_2s14.jpg GRAPHIC 419470
18 GRAPHIC cgem-ex99_2s15.jpg GRAPHIC 283328
19 GRAPHIC cgem-ex99_2s16.jpg GRAPHIC 486143
20 GRAPHIC cgem-ex99_2s17.jpg GRAPHIC 345742
  Complete submission text file 0000950170-25-081601.txt   10532551

Data Files

Seq Description Document Type Size
21 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cgem-20250604.xsd EX-101.SCH 24922
31 EXTRACTED XBRL INSTANCE DOCUMENT cgem-20250604_htm.xml XML 4711
Mailing Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 1350 CAMBRIDGE MA 02142 617-410-4650
Cullinan Therapeutics, Inc. (Filer) CIK: 0001789972 (see all company filings)

EIN.: 813879991 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39856 | Film No.: 251023085
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)